SAB Biotherapeutics (SABS) EBITDA (2021 - 2026)
SAB Biotherapeutics (SABS) posted EBITDA of -$22.58 million for Q2 2026, compared with -$8.93 million a year earlier.
Powered by 
Analysis
SAB Biotherapeutics (SABS) EBITDA (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at SAB Biotherapeutics was -$68.89 million; for FY2025, it was -$45.95 million.
- In prior years, SAB Biotherapeutics' EBITDA was -$38.2 million in FY2024, -$34.38 million in FY2023, -$25.72 million in FY2022 and -$11.9 million in FY2021.
- The Q2 2026 figure stands as the lowest quarterly EBITDA in data going back to Q1 2021.
- According to Business Quant data, EBITDA for the three prior quarters was -$19.27 million (Q1 2026), -$15.07 million (Q4 2025) and -$11.98 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 5.89 Bn |
| 10 | SAB Biotherapeutics | 223.71 Mn | -193.79 Mn | - | -22.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22.56 Mn |
| Mar 31, 2026 | -19.24 Mn |
| Dec 31, 2025 | -15.04 Mn |
| Sep 30, 2025 | -11.96 Mn |
| Jun 30, 2025 | -8.91 Mn |
| Mar 31, 2025 | -9.95 Mn |
| Dec 31, 2024 | -9.21 Mn |
| Sep 30, 2024 | -10.39 Mn |
| Jun 30, 2024 | -9.18 Mn |
| Mar 31, 2024 | -9.37 Mn |
| Dec 31, 2023 | -17.87 Mn |
| Sep 30, 2023 | -4.30 Mn |
| Jun 30, 2023 | -5.55 Mn |
| Mar 31, 2023 | -6.48 Mn |
| Dec 31, 2022 | -6.91 Mn |
| Sep 30, 2022 | -6.89 Mn |
| Jun 30, 2022 | -5.76 Mn |
| Mar 31, 2022 | -6.03 Mn |
| Dec 31, 2021 | -6.68 Mn |
| Sep 30, 2021 | -3.58 Mn |
API Access
SAB Biotherapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=SABS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();